http://crnano.typepa...row_and_to.html
Should CRN look at the consequences of life-extension in relation to fully developed molecular nanotechnology?
Should life-extension be a factor when deciding how nanofactories might be developed in a safe and manageable way?
Though the safe development of nanofactories should be achieved in the short term, the availability of unrestricted nanofactories will be essential to the development of diversity in a transhuman world. I think it would be wrong to place restrictions on development and production of aging intervention methods on any nanofactory, short or long term.